ALT - Altimmune, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (3Y Monthly) 2.48
52-Week Change 3-53.29%
S&P500 52-Week Change 317.82%
52 Week High 35.9400
52 Week Low 31.5100
50-Day Moving Average 31.8905
200-Day Moving Average 32.2081

Share Statistics

Avg Vol (3 month) 3107.06k
Avg Vol (10 day) 3205.67k
Shares Outstanding 515.34M
Float 11.67M
% Held by Insiders 114.29%
% Held by Institutions 11.67%
Shares Short (Oct 31, 2019) 4686.96k
Short Ratio (Oct 31, 2019) 49.58
Short % of Float (Oct 31, 2019) 45.24%
Short % of Shares Outstanding (Oct 31, 2019) 44.48%
Shares Short (prior month Sep 30, 2019) 4831.17k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Feb 3, 2017
Ex-Dividend Date 4Jan 20, 2017
Last Split Factor (new per old) 230/1
Last Split Date 3Sep 14, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)-235.07%

Management Effectiveness

Return on Assets (ttm)-21.02%
Return on Equity (ttm)-91.91%

Income Statement

Revenue (ttm)7.81M
Revenue Per Share (ttm)0.68
Quarterly Revenue Growth (yoy)-75.60%
Gross Profit (ttm)-8.13M
EBITDA -17.94M
Net Income Avi to Common (ttm)-42.16M
Diluted EPS (ttm)-3.6900
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)39.2M
Total Cash Per Share (mrq)2.61
Total Debt (mrq)1.91M
Total Debt/Equity (mrq)3.87
Current Ratio (mrq)16.87
Book Value Per Share (mrq)3.29

Cash Flow Statement

Operating Cash Flow (ttm)-12.76M
Levered Free Cash Flow (ttm)-13.25M